Correction: CuI-mediated synthesis of 1-aryl-5,6,7-trimethoxybenzimidazoles as potent antitubulin agents

Cong-Min Peng; Shih-Wei Wang; Yi-Lin Hwang; Wen-Chun Sun; Li-Pin Chiu; Yi-Ting Liu; Yu-Wei Lai; Hsueh-Yun Lee

doi:10.1039/d3ra90046k

Correction: CuI-mediated synthesis of 1-aryl-5,6,7-trimethoxybenzimidazoles as potent antitubulin agents

RSC Adv. 2023 May 16;13(22):14878. doi: 10.1039/d3ra90046k. eCollection 2023 May 15.

Authors

Cong-Min Peng¹, Shih-Wei Wang^{2

3

4}, Yi-Lin Hwang¹, Wen-Chun Sun^{2

5}, Li-Pin Chiu^{6

7}, Yi-Ting Liu¹, Yu-Wei Lai^{8

9}, Hsueh-Yun Lee^{1

10

11}

Affiliations

¹ School of Pharmacy, College of Pharmacy, Taipei Medical University Taipei Taiwan hyl@tmu.edu.tw.
² Institute of Biomedical Sciences, MacKay Medical College New Taipei City Taiwan.
³ Department of Medicine, MacKay Medical College New Taipei City Taiwan.
⁴ School of Pharmacy, College of Pharmacy, Kaohsiung Medical University Kaohsiung Taiwan.
⁵ Division of Colon and Rectal Surgery, Department of Surgery, MacKay Memorial Hospital Taipei Taiwan.
⁶ Division of General Surgery, Taipei City Hospital Chushing Branch Taipei Taiwan.
⁷ General Education Center, University of Taipei Taipei Taiwan.
⁸ Division of Urology, Taipei City Hospital Renai Branch Taipei Taiwan dai77@tpech.gov.tw.
⁹ Department of Urology, School of Medicine and Shu-Tien Urological Science Research Center, National Yang Ming Chiao Tung University Taipei Taiwan.
¹⁰ PhD Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University Taipei Taiwan.
¹¹ TMU Research Center of Cancer Translational Medicine, Taipei Medical University Taipei Taiwan.

Abstract

[This corrects the article DOI: 10.1039/D3RA01927F.].

Publication types

Published Erratum